Xet CR 25 Tablet contains Paroxetine 25 mg, a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder, generalized anxiety disorder, panic disorder, social anxiety disorder, and obsessive-compulsive disorder. Paroxetine acts by increasing serotonin levels in the brain, thereby helping to restore the balance of neurotransmitters and improve mood and anxiety symptoms. Xet CR 25 Tablet is formulated as a controlled-release preparation to provide a consistent therapeutic effect and minimize fluctuations in plasma concentration, enhancing tolerability and adherence. The medication is typically administered once daily, preferably in the morning, with or without food. Common side effects may include nausea, dizziness, dry mouth, somnolence, and sexual dysfunction, which often diminish with continued use. It is essential to monitor patients for any signs of worsening depression, suicidal ideation, or unusual behavioral changes, especially during the initial treatment period or dose adjustments. Xet CR 25 should be used cautiously in patients with a history of bipolar disorder, seizures, or bleeding disorders. Abrupt discontinuation is not recommended due to the risk of withdrawal symptoms; gradual tapering under medical supervision is advised. This medication should be prescribed and used under the guidance of a qualified healthcare professional.